Swiss National Bank
FURX

Swiss National Bank’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Swiss National Bank’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-8,300
Closed -$881K – 2545
2014
Q2 		$881K Buy
8,300
+500
+6% +$49K ﹤0.01% 1798
2014
Q1 		$679K Buy
7,800
+1,400
+22% +$108K ﹤0.01% 1948
2013
Q4 		$269K Buy
6,400
+2,900
+83% +$119K ﹤0.01% 2311
2013
Q3 		$154K Hold
3,500
– – ﹤0.01% 2410
2013
Q2 		$119K Buy
+3,500
New +$123K ﹤0.01% 2456

Swiss National Bank's FURX Position: Q3 2014 in Review

Swiss National Bank sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 8,300 shares — an estimated $881K sold.

Swiss National Bank first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $881K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Swiss National Bank reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Swiss National Bank sold 8,300 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $881K.
  • Swiss National Bank first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Swiss National Bank's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $881K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Swiss National Bank's 13F filing for Q3 2014, filed 4 Nov 2014.